Actively Recruiting
Fast Discharge After Acute Myocardial Infarction Discharge MI
Led by Medical University Innsbruck · Updated on 2026-03-16
2070
Participants Needed
8
Research Sites
265 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To evaluate the hypothesis that a fast discharge strategy (discharge at 24 \[± 12\] hours) following invasive management for acute myocardial infarction is non-inferior to standard of care (\>36 hours) with respect to the risk of major adverse cardiovascular events (MACE) during follow-up.
CONDITIONS
Official Title
Fast Discharge After Acute Myocardial Infarction Discharge MI
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Uncomplicated acute myocardial infarction (NSTEMI and STEMI) diagnosed according to the 2023 acute coronary syndrome guidelines of the ESC
- Age 18 years at time of consent
- Invasive management strategy with successful PCI intervention of the culprit lesion defined by post-interventional TIMI 3 flow
- Ability to understand and willing to sign written informed consent
You will not qualify if you...
- Myocardial infarction complicated by cardiac arrest
- PCI-related complications including coronary perforation, side branch closure, inability to deliver stent/balloon, aortic dissection, allergic reaction grade 2, stroke/thromboembolism, access site complications
- Malignant arrhythmias such as sustained ventricular arrhythmias and persistent bradycardia (<50 beats per minute), second-/third-degree atrioventricular block after PCI
- Ongoing hemodynamic instability (systolic blood pressure <90 mmHg, elevated lactate, need for inotropes or vasopressors)
- Ongoing respiratory instability defined by Killip class >I (rales, pulmonary edema)
- Ongoing disorders of consciousness (somnolence, sopor, coma)
- Acute kidney injury defined by KDIGO stages 2 and 3
- Pregnancy
- Untreated critical non-culprit lesions requiring revascularization during hospitalization
- Immobility, limited mobility, or social situations preventing fast discharge as assessed by care team
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 8 locations
1
Hospital Wiener Neustadt
Wiener Neustadt, Lower Austria, Austria, 2700
Actively Recruiting
2
Cardinal Schwarzenberg Hospital Schwarzach
Schwarzach im Pongau, Schwarzach Im Pongau, Austria, 5620
Not Yet Recruiting
3
Paracelsus Medical University Salzburg
Salzburg, State of Salzburg, Austria, 5020
Actively Recruiting
4
Medical University of Graz
Graz, Styria, Austria, 8010
Actively Recruiting
5
Medical University of Innsbruck
Innsbruck, Tyrol, Austria, 6020
Actively Recruiting
6
University Teaching Hospital Wels-Grieskirchen
Wels, Upper Austria, Austria, 4600
Actively Recruiting
7
Academic Teaching Hospital Feldkirch
Feldkirch, Vorarlberg, Austria, 6800
Actively Recruiting
8
Ludwig Maximilian University Munich
Munich, Bavaria, Germany, 81377
Not Yet Recruiting
Research Team
M
Martin Reindl, MD, PhD
CONTACT
I
Ivan Lechner, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here